These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29556130)

  • 21. Pharmaceutical Pricing Policies and Procedures in Saudi Arabia: A Narrative Review.
    Khan TM; Emeka P; Suleiman AK; Alnutafy FS; Aljadhey H
    Ther Innov Regul Sci; 2016 Mar; 50(2):236-240. PubMed ID: 30227009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Public awareness and perception toward Adverse Drug Reactions reporting in Riyadh, Saudi Arabia.
    Sales I; Aljadhey H; Albogami Y; Mahmoud MA
    Saudi Pharm J; 2017 Sep; 25(6):868-872. PubMed ID: 28951672
    [No Abstract]   [Full Text] [Related]  

  • 23. Perspective of Saudi undergraduate pharmacy students on pharmacovigilance and adverse drug reaction reporting: A National Survey.
    Alkayyal N; Cheema E; Hadi MA
    Curr Pharm Teach Learn; 2017 Sep; 9(5):779-785. PubMed ID: 29233304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Jordan Food and Drug Administration: Comparison of its Registration Process with Australia, Canada, Saudi Arabia and Singapore.
    Haqaish WSA; Obeidat H; Patel P; Walker S
    Pharmaceut Med; 2017; 31(1):21-30. PubMed ID: 28572733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of the National pharmacovigilance system in Malta - implementing and operating a pharmacovigilance management system.
    Tanti A; Micallef B; Serracino-Inglott A; Borg JJ
    Expert Opin Drug Saf; 2017 Jan; 16(1):65-76. PubMed ID: 27732110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacovigilance in healthcare education: students' knowledge, attitude and perception: a cross-sectional study in Saudi Arabia.
    Alwhaibi M; Alhindi G; Alshamrani M; Essa MB; A Al Aloola N; Alhawassi TM
    BMC Med Educ; 2020 Jul; 20(1):210. PubMed ID: 32616054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unlocking the eHealth professionals' career pathways: A case of Gulf Cooperation Council countries.
    Zakaria N; Zakaria N; Alnobani O; AlMalki M; El-Hassan O; Alhefzi MI; Househ M; Jamal A
    Int J Med Inform; 2023 Feb; 170():104914. PubMed ID: 36521421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring the manufacturing and quality of medicines: a fundamental task of pharmacovigilance.
    Sardella M; Belcher G; Lungu C; Ignoni T; Camisa M; Stenver DI; Porcelli P; D'Antuono M; Castiglione NG; Adams A; Furlan G; Grisoni I; Hall S; Boga L; Mancini V; Ciuca M; Chonzi D; Edwards B; Mangoni AA; Tuccori M; Prokofyeva E; De Gregorio F; Bertazzoli Grabinski Broglio M; van Leeuwen B; Kruger P; Rausch C; Le Louet H
    Ther Adv Drug Saf; 2021; 12():20420986211038436. PubMed ID: 34394910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa.
    Kiguba R; Olsson S; Waitt C
    Br J Clin Pharmacol; 2023 Feb; 89(2):491-509. PubMed ID: 34937122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The perspective of pharmacist on pharmacovigilance and adverse drug reaction reporting in Asir region, Saudi Arabia.
    Alghazwani Y; Alqahtani AM; Alshuraymi MK; Assiri IM; Shuflut AA; Krishnaraju V; Kumarappan C; Ibrahim ARN; Orayj K
    Eur Rev Med Pharmacol Sci; 2023 Feb; 27(4):1667-1680. PubMed ID: 36876701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eritrean Pharmacovigilance System: Key Strategies, Success Stories, Challenges and Lessons Learned.
    Russom M; Bahta I; Debesai M
    Drug Saf; 2021 Oct; 44(10):1021-1032. PubMed ID: 34472048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacovigilance in China: Evolution and future challenges.
    Song H; Pei X; Liu Z; Shen C; Sun J; Liu Y; Zhou L; Sun F; Xiao X
    Br J Clin Pharmacol; 2023 Feb; 89(2):510-522. PubMed ID: 35165914
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experience of safety monitoring in the context of a prospective observational study of artemether-lumefantrine in rural Tanzania: lessons learned for pharmacovigilance reporting.
    Kabanywanyi AM; Mulure N; Migoha C; Malila A; Lengeler C; Schlienger R; Genton B
    Malar J; 2010 Jul; 9():205. PubMed ID: 20630066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What place for intelligent automation and artificial intelligence to preserve and strengthen vigilance expertise in the face of increasing declarations?
    Pariente A; Micallef J; Lahouegue A; Molimard M; Auffret M; Chouchana L; Denis B; Faillie JL; Grandvuillemin A; Letinier L; Pierron E; Pons C; Pujade I; Rubino H; Salvo F
    Therapie; 2023; 78(1):131-143. PubMed ID: 36572627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The comparative assessment of awareness, perspective, and basic practice skills about the Saudi pharmacovigilance system among students of different health-care professionals of a Saudi Female University.
    Bepari A; Assiri RA; AlYahya MA; AlGhamdi SJ; AlGhamdi AM; AlOnazi AA
    Saudi Pharm J; 2020 Jul; 28(7):828-836. PubMed ID: 32647484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient-centered pharmacovigilance: priority actions from the inherited bleeding disorders community.
    Robinson F; Wilkes S; Schaefer N; Goldstein M; Rice M; Gray J; Meyers S; Valentino LA
    Ther Adv Drug Saf; 2023; 14():20420986221146418. PubMed ID: 36861041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Healthcare transformation journey in the Eastern Region of Saudi Arabia: an overview, challenges and lessons learned.
    Yousef L; AlAngari D; AlShehri R; AlSharif B; Bayameen O; Alnemer Z
    J Med Life; 2023 Apr; 16(4):583-592. PubMed ID: 37305832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Saudi Arabia Food and Drug Authority: An Evaluation of the Registration Process and Good Review Practices in Saudi Arabia in Comparison with Australia, Canada and Singapore.
    Hashan H; Aljuffali I; Patel P; Walker S
    Pharmaceut Med; 2016; 30():37-47. PubMed ID: 26834481
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.